Anixa Biosciences (ANIX) Revenue & Revenue Breakdown
Anixa Biosciences Revenue Highlights
Latest Revenue (Y)
$210.00K
Main Segment (Y)
Patent Licensing
Main Geography (Y)
Patent Licensing
Anixa Biosciences Revenue by Period
Anixa Biosciences Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-10-31 | $210.00K | -99.99% |
| 2022-10-31 | $2.47B | 481656.10% |
| 2021-10-31 | $512.50K | 100.00% |
| 2020-10-31 | - | -100.00% |
| 2019-10-31 | $250.00K | -77.53% |
| 2018-10-31 | $1.11M | 206.90% |
| 2017-10-31 | $362.50K | 20.83% |
| 2016-10-31 | $300.00K | -96.76% |
| 2015-10-31 | $9.26M | 152.36% |
| 2014-10-31 | $3.67M | 843.12% |
| 2013-10-31 | $388.85K | -58.94% |
| 2012-10-31 | $947.09K | -5.59% |
| 2011-10-31 | $1.00M | 37.30% |
| 2010-10-31 | $730.67K | -30.79% |
| 2009-10-31 | $1.06M | -48.83% |
| 2008-10-31 | $2.06M | 323.77% |
| 2007-10-31 | $486.85K | -4.29% |
| 2006-10-31 | $508.65K | 15.66% |
| 2005-10-31 | $439.79K | -11.06% |
| 2004-10-31 | $494.46K | 102.46% |
| 2003-10-31 | $244.22K | -95.29% |
| 2002-10-31 | $5.19M | 206.77% |
| 2001-10-31 | $1.69M | 14.86% |
| 2000-10-31 | $1.47M | 1372.00% |
| 1999-10-31 | $100.00K | -50.00% |
| 1998-10-31 | $200.00K | 100.00% |
| 1997-10-31 | $100.00K | - |
| 1996-10-31 | $100.00K | - |
| 1995-10-31 | $100.00K | - |
| 1994-10-31 | $100.00K | - |
| 1993-10-31 | $100.00K | - |
Anixa Biosciences generated $210.00K in revenue during NA 2023, up -99.99% compared to the previous quarter, and up 18.88% compared to the same period a year ago.
Anixa Biosciences Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-07-31 | - | 100.00% |
| 2024-04-30 | - | 100.00% |
| 2024-01-31 | - | -100.00% |
| 2023-10-31 | $156.00K | 100.00% |
| 2023-07-31 | - | -100.00% |
| 2023-04-30 | $210.00K | 100.00% |
| 2023-01-31 | - | -100.00% |
| 2022-10-31 | $2.47B | 100.00% |
| 2022-07-31 | - | 100.00% |
| 2022-04-30 | - | 100.00% |
| 2022-01-31 | - | -100.00% |
| 2021-10-31 | $3.61M | 100.00% |
| 2021-07-31 | - | 100.00% |
| 2021-04-30 | - | -100.00% |
| 2021-01-31 | $512.50K | -512.11% |
| 2020-10-31 | $-124.36K | 100.00% |
| 2020-07-31 | - | 100.00% |
| 2020-04-30 | - | 100.00% |
| 2020-01-31 | - | -100.00% |
| 2019-10-31 | $-259.48K | 100.00% |
| 2019-07-31 | - | -100.00% |
| 2019-04-30 | $250.00K | 100.00% |
| 2019-01-31 | - | -100.00% |
| 2018-10-31 | $-1.42M | -491.84% |
| 2018-07-31 | $362.50K | -51.67% |
| 2018-04-30 | $750.00K | 100.00% |
| 2018-01-31 | - | -100.00% |
| 2017-10-31 | $-74.91K | -120.66% |
| 2017-07-31 | $362.50K | 100.00% |
| 2017-04-30 | - | 100.00% |
| 2017-01-31 | - | -100.00% |
| 2016-10-31 | $200.00K | 100.00% |
| 2016-07-31 | $100.00K | 100.00% |
| 2016-04-30 | - | 100.00% |
| 2016-01-31 | - | 100.00% |
| 2015-10-31 | - | -100.00% |
| 2015-07-31 | $95.00K | 280.00% |
| 2015-04-30 | $25.00K | -99.73% |
| 2015-01-31 | $9.13M | 564.36% |
| 2014-10-31 | $1.38M | 15.81% |
| 2014-07-31 | $1.19M | 7.45% |
| 2014-04-30 | $1.10M | 100.00% |
| 2014-01-31 | - | -100.00% |
| 2013-10-31 | $386.72K | 100.00% |
| 2013-07-31 | - | 100.00% |
| 2013-04-30 | - | -100.00% |
| 2013-01-31 | $2.13K | 508.57% |
| 2012-10-31 | $350.00 | -99.86% |
| 2012-07-31 | $249.47K | 0.56% |
| 2012-04-30 | $248.07K | -44.77% |
| 2012-01-31 | $449.19K | 0.05% |
| 2011-10-31 | $448.96K | -0.31% |
| 2011-07-31 | $450.36K | 418.16% |
| 2011-04-30 | $86.92K | 412.53% |
| 2011-01-31 | $16.96K | -94.55% |
| 2010-10-31 | $311.25K | 436.36% |
| 2010-07-31 | $58.03K | -82.01% |
| 2010-04-30 | $322.52K | 729.75% |
| 2010-01-31 | $38.87K | -67.38% |
| 2009-10-31 | $119.16K | -60.25% |
| 2009-07-31 | $299.76K | 14.09% |
| 2009-04-30 | $262.75K | -29.77% |
| 2009-01-31 | $374.12K | -61.17% |
| 2008-10-31 | $963.41K | 9.21% |
| 2008-07-31 | $882.13K | 433.48% |
| 2008-04-30 | $165.35K | 216.62% |
| 2008-01-31 | $52.23K | - |
Anixa Biosciences generated - in revenue during Q3 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Anixa Biosciences Revenue Breakdown
Anixa Biosciences Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Oct 19 |
|---|---|
| Patent Licensing | $250.00K |
Anixa Biosciences's latest annual revenue breakdown by segment (product or service), as of Oct 19: Patent Licensing (100.00%).
Anixa Biosciences Revenue Breakdown by Country
Annual Revenue by Country
| Country | Oct 19 |
|---|---|
| Patent Licensing | $250.00K |
Anixa Biosciences's latest annual revenue breakdown by geography, as of Oct 19: Patent Licensing (100.00%).
Anixa Biosciences Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ACLX | Arcellx | $110.32M | $27.38M |
| ADAG | Adagene | $18.11M | $833.34K |
| IMNM | Immunome | $14.02M | $2.36M |
| MOLN | Molecular Partners | $7.04M | $2.74M |
| CUE | Cue Biopharma | $5.49M | $1.72M |
| TFFP | TFF Pharmaceuticals | $733.87K | $650.22K |
| ANIX | Anixa Biosciences | $210.00K | - |
| ANEB | Anebulo Pharmaceuticals | - | - |
| RZLT | Rezolute | - | - |
| ANTX | AN2 Therapeutics | - | - |
| AVTE | Aerovate Therapeutics | - | - |
| INAB | IN8bio | - | - |
| ACRV | Acrivon Therapeutics | - | - |
| PMVP | PMV Pharmaceuticals | - | - |
| MLYS | Mineralys Therapeutics | - | - |
| PYPD | PolyPid | - | - |
| ANVS | Annovis Bio | - | - |
| INMB | INmune Bio | $-155.00K | - |
ANIX Revenue FAQ
What is Anixa Biosciences’s yearly revenue?
Anixa Biosciences's yearly revenue for 2023 was $210K, representing a decrease of -99.99% compared to 2022. The company's yearly revenue for 2022 was $2.47B, representing an increase of 481656.10% compared to 2021. ANIX's yearly revenue for 2021 was $512.5K, representing an increase of 100.00% compared to 2020.
What is Anixa Biosciences’s quarterly revenue?
Anixa Biosciences's quarterly revenue for Q3 2024 was $0, a 100.00% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a -100.00% decrease year-over-year (Q2 2023). ANIX's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023).
What is Anixa Biosciences’s revenue growth rate?
Anixa Biosciences's revenue growth rate for the last 3 years (2021-2023) was -59.02%, and for the last 5 years (2019-2023) was -16.00%.
What are Anixa Biosciences’s revenue streams?
Anixa Biosciences's revenue streams in t 19 are Patent Licensing
What is Anixa Biosciences’s main source of revenue?
For the fiscal year ending Oct 19, the largest source of revenue of Anixa Biosciences was Patent Licensing. This segment made a revenue of $250K, representing 100.00% of the company's total revenue.